PROFESSIONAL WOMEN’S HOCKEY LEAGUE (PWHL) ANNOUNCES AIRSUPRA AS FIRST U.S. FOUNDING PARTNER

AIRSUPRA® (albuterol/budesonide) to Become the Official Pharmaceutical Sponsor of the PWHL in 2024

 

TORONTO, ON (February 28, 2024) – The Professional Women’s Hockey League (PWHL) has announced today that AIRSUPRA® (albuterol/budesonide) Inhalation Aerosol is the league’s first U.S. Founding Partner and will be the Official Pharmaceutical Brand of the PWHL in 2024.

 

AIRSUPRA® (albuterol/budesonide) Inhalation Aerosol, is a first-in-class, fixed-dose combination rescue medication to be taken as needed for the treatment or prevention of symptoms of asthma and to help prevent sudden severe breathing problems (asthma attacks) in people aged 18 years and older.

 

“We are proud to welcome AIRSUPRA to the PWHL community as our first Founding Partner in the United States,” said sports icon and PWHL Advisory Board member Billie Jean King. “The support of AIRSUPRA underscores its belief in women’s hockey and its commitment to our great league. We are looking forward to a truly fantastic relationship.”

 

AIRSUPRA’s partnership includes shoulder patches on jerseys of the league’s three U.S. teams in Boston, Minnesota, and New York. AIRSUPRA will have multiple game activations and giveaways in U.S. markets throughout the season, along with in-arena signage, broadcast components, digital integration, and unique social media content across league and team platforms.

 

The inaugural PWHL regular season began on January 1, 2024, and includes 72 games through May 5, 2024, followed by playoffs.

 

IMPORTANT SAFETY INFORMATION

 

  • Do not use AIRSUPRA if you are allergic to albuterol, budesonide, or any of the ingredients in AIRSUPRA
  • Before using AIRSUPRA, tell your healthcare provider about all your medical conditions and about all the medicines you take
  • A dose of AIRSUPRA is 2 inhalations (puffs) as needed. Use AIRSUPRA exactly as your healthcare provider tells you to use it. Do not use AIRSUPRA more than 12 puffs (which equals 6 doses) within a 24-hour period
  • AIRSUPRA is not to be used as a maintenance treatment for asthma. If you are currently taking medicine long-term to maintain control of asthma symptoms, you should continue to take that medicine as directed by your healthcare provider
  • Do not change or stop other inhaled medicines or asthma medicines (oral or inhaled) without first talking to your healthcare provider
  • Call your healthcare provider or get emergency medical care right away if your breathing problems get worse, you need to use AIRSUPRA more often than usual, or AIRSUPRA does not work as well to relieve your asthma
  • AIRSUPRA can cause serious side effects, including:
    • worsening trouble breathing, coughing, and wheezing (paradoxical bronchospasm). If this happens, stop using AIRSUPRA and call your healthcare provider or get emergency medical care right away. This is more likely to happen with your first use of a new canister of medicine
    • heart problems, including faster heart rate and higher blood pressure
    • possible death in people who use too much AIRSUPRA
    • serious allergic reactions. Tell your healthcare provider or get emergency medical care right away if you have a skin rash, redness, or swelling; severe itching; swelling of the face, mouth, or tongue; trouble breathing or swallowing; or chest pain
    • changes in laboratory blood levels. Low levels of potassium (hypokalemia) may cause abnormal heart rhythms
    • weakened immune system and increased chance of getting infections
    • fungal infection in your mouth and throat (thrush). This is a common side effect. Rinse your mouth with water, if available, without swallowing after using AIRSUPRA to help reduce your chance of getting thrush
    • reduced adrenal function (adrenal insufficiency). This can happen when you start taking a medicine containing an inhaled corticosteroid (such as AIRSUPRA)
    • bone thinning or weakness (osteoporosis)
    • eye problems, including glaucoma and cataracts. Your healthcare provider may suggest having regular eye exams while using AIRSUPRA. Discuss any eye problems with your healthcare provider
  • Common side effects include headache, cough, and hoarseness. These are not all the side effects of AIRSUPRA. For more information, ask your healthcare provider or pharmacist

 

APPROVED USE

 

AIRSUPRA combines 2 medicines to be used as needed as a rescue inhaler in people 18 years of age and older to:

  • treat or prevent symptoms of asthma
  • help prevent sudden severe breathing problems (asthma attacks or exacerbations)

 

Please see full Prescribing Information and Patient Information and discuss with your doctor.

You may report side effects related to AstraZeneca products.

 

About the Professional Women’s Hockey League (PWHL)

The Professional Women’s Hockey League (PWHL) is a professional ice hockey league in North America comprised of six teams in Boston, Minnesota, Montreal, New York, Ottawa, and Toronto, each with rosters featuring the best women’s hockey players in the world. Visit thepwhl.com to purchase tickets and merchandise, and subscribe to the PWHL e-newsletter to receive the latest league updates. Follow the league on all social media platforms @thepwhlofficial plus all six team accounts @pwhl_boston, @pwhl_minnesota, @pwhl_montreal, @pwhl_newyork, @pwhl_ottawa, and @pwhl_toronto.

 

###